John Freund
Director/Board Member en SI-BONE, INC. .
Fortuna: 4 M $ al 31/03/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michael Heffernan | M | 59 | 22 años | |
Garen Bohlin | M | 76 |
Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sirtris Pharmaceuticals, Inc., a GSK company, is developing small molecule drugs that target the sirtuins, a family of seven enzymes associated with diseases of aging. Modulation of these enzymes offers the promise of drug discovery in multiple therapeutic areas. Sirtris was one of the pharmaceutical companies focused on the sirtuin platform and remains the innovative drug discovery. Preclinical research indicates that the sirtuins play important roles in pathways for multiple diseases of aging, including Type 2 Diabetes, as well as neurodegenerative, cardiovascular and inflammatory diseases. Sirtris researchers are working to translate this research into a potential new class of pharmaceuticals to treat diseases of aging, offering the ability for people to live longer, healthier lives. Sirtris has focused on developing many novel small molecule activators of SIRT1, the most studied member of the sirtuin family. These new chemical entities or NCEs are novel compounds that are chemically unrelated to resveratrol, a naturally occurring compound that was used as an early proof-of-concept for SIRT1 activation. Besides being structurally differentiated from resveratrol, the NCEs are more specific for the target SIRT1 and have improved drug-like properties. The company has completed several early stage translational clinical studies with the first generation NCEs and has several active clinical trials under way. Sirtris operates as an independent Discovery Performance Unit (DPU) within GSK and is located in Technology Square, Cambridge, Mass. Sirtris' culture mixes scientific curiosity with a dynamic, fast-paced environment, resembling its biotech roots while harnessing all of GSK's broad discovery, development, and commercialization capabilities. The company was founded in 2004 and is headquartered in Cambridge, MA. | 18 años |
Michael A. Pisetsky | M | 46 | 9 años | |
Jeffrey Dunn | M | 69 | 16 años | |
Joseph Ciaffoni | M | 53 | 7 años | |
Gary Guthart | M | 58 | 28 años | |
Laura Francis | F | 57 | 9 años | |
Jeryl Hilleman | F | 66 | 20 años | |
David Patteson | M | 69 |
Advion BioSciences, Inc.
Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | - |
Leonade D. Jones | F | 76 |
American Funds Fundamental Investors
Smallcap World Fund
The Growth Fund of America
| - |
Joseph W. Powers | M | 65 | 15 años | |
David N. Chernoff | M | - |
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | - |
Jack D. Henion | M | - |
Advion BioSciences, Inc.
Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | 31 años |
Shirley Kuhlmann | F | 40 | 6 años | |
William Newell | M | 66 | 15 años | |
Dave Rosa Rosa | M | 56 | 28 años | |
Jane Chung | F | 53 | 3 años | |
Richard G. Capen | M | 89 |
Smallcap World Fund
| 31 años |
Linda Griego | F | 76 |
The Growth Fund of America
American Funds Fundamental Investors
Smallcap World Fund
| - |
Nikolas F. Kerr | M | 53 | 8 años | |
Helen Loh | F | 60 | 3 años | |
Jeff Bertolini | M | - | 2 años | |
Heidi Hunter | F | 66 | 3 años | |
Mika Nishimura | F | 60 | 3 años | |
Jon Wigginton | M | 62 | 4 años | |
Daniel Joseph Cher | M | - | 12 años | |
W. Carlton Reckling | M | 62 | 12 años | |
Rita Balice-Gordon | M | 63 | 4 años | |
Nicki Vasquez | M | 61 | 9 años | |
Anshul Maheshwari | M | 44 | 3 años | |
Michael P. Ember | M | - |
McNally Capital LLC
McNally Capital LLC Investment ManagersFinance McNally Capital LLC (McNally Capital) is a venture capital firm founded in 2008 by Ward S. McNally and John P. Rompon. The firm is headquartered in Chicago, Illinois. | 7 años |
Neil McFarlane | M | 51 | 2 años | |
Michael Blanchard | M | - | 10 años | |
Lou Rassey | M | 50 |
McNally Capital LLC
McNally Capital LLC Investment ManagersFinance McNally Capital LLC (McNally Capital) is a venture capital firm founded in 2008 by Ward S. McNally and John P. Rompon. The firm is headquartered in Chicago, Illinois. | - |
Scott Sudduth | M | - | 6 años | |
Henry Heinsohn | M | - | - | |
Scott Dreyer | M | 52 | 6 años | |
Robyn Capobianco | M | - | 3 años | |
Myria Crawford | F | - |
Medivance, Inc.
Medivance, Inc. Medical SpecialtiesHealth Technology Medivance, Inc. develops, manufactures and markets therapeutic temperature management products. The company was founded in 1998 and is headquartered in Louisville, CO. | - |
Timothy Davis | M | 53 | 16 años | |
Daniel Petree | M | 68 | - | |
Joseph Lobacki | M | 65 | 7 años | |
Gregory Hinckley | M | 77 | 13 años | |
Gwen Melincoff | M | 72 | 7 años | |
Edward Albini | M | 66 | 11 años | |
Michael Dybbs | M | 49 | 6 años | |
Linda Fitzpatrick | F | 67 | 16 años | |
Keith Valentine | M | 56 | 9 años | |
James Panek | M | 71 | 4 años | |
Connie Matsui | F | 70 | 5 años | |
Eric M. Gordon | M | 78 |
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | 22 años |
John Fallon | M | 76 | 8 años | |
Ward S. McNally | M | - |
McNally Capital LLC
McNally Capital LLC Investment ManagersFinance McNally Capital LLC (McNally Capital) is a venture capital firm founded in 2008 by Ward S. McNally and John P. Rompon. The firm is headquartered in Chicago, Illinois. | 17 años |
Joseph M. Kiely | M | - |
Advion BioSciences, Inc.
Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | - |
Gary A. Carson | M | - |
Medivance, Inc.
Medivance, Inc. Medical SpecialtiesHealth Technology Medivance, Inc. develops, manufactures and markets therapeutic temperature management products. The company was founded in 1998 and is headquartered in Louisville, CO. | - |
Gino Santini | M | 66 | 12 años | |
Sandy McNally | M | 84 |
McNally Capital LLC
McNally Capital LLC Investment ManagersFinance McNally Capital LLC (McNally Capital) is a venture capital firm founded in 2008 by Ward S. McNally and John P. Rompon. The firm is headquartered in Chicago, Illinois. | - |
Kevin Tang | M | 57 | 4 años | |
Colleen Tupper | F | 48 | 3 años | |
Craig Johnson | M | 62 | 4 años | |
Francis H. Zenie | M | - |
Advion BioSciences, Inc.
Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | - |
Dan K. Huston | M | - |
Advion BioSciences, Inc.
Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | 18 años |
Zach Shulman | M | - |
Advion BioSciences, Inc.
Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Frederic Moll | M | 72 | 16 años | |
Larry G. Edwards | M | 52 | 5 años | |
Daniel T. Wallace | M | 57 | 6 años | |
Guy L. de Chazal | M | 76 |
Morgan Stanley Venture Partners
Morgan Stanley Venture Partners Investment ManagersFinance Morgan Stanley Venture Partners (MSVP) is a venture capital firm subsidiary of Morgan Stanley Investment Management Merchant Banking, which is ultimately owned by Morgan Stanley (NYSE: MWD) founded in 1986.The firm is headquartered in New York.
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | 21 años |
Wendell Wierenga | M | 76 | 16 años | |
Vincent Angotti | M | 56 | 8 años | |
William Rieflin | M | 64 | 12 años | |
Robert G. Younge | M | 71 | 7 años | |
Ronald W. Barrett | M | 68 | 16 años | |
Lonnie Smith | M | 79 | 23 años | |
Douglas Cole | M | 63 | 7 años | |
Daniel Janney | M | 58 | - | |
Gary C. Restani | M | 77 | 3 años | |
Lawrence G. Miller | M | 70 | 7 años | |
Paul Brannelly | M | 51 |
Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sirtris Pharmaceuticals, Inc., a GSK company, is developing small molecule drugs that target the sirtuins, a family of seven enzymes associated with diseases of aging. Modulation of these enzymes offers the promise of drug discovery in multiple therapeutic areas. Sirtris was one of the pharmaceutical companies focused on the sirtuin platform and remains the innovative drug discovery. Preclinical research indicates that the sirtuins play important roles in pathways for multiple diseases of aging, including Type 2 Diabetes, as well as neurodegenerative, cardiovascular and inflammatory diseases. Sirtris researchers are working to translate this research into a potential new class of pharmaceuticals to treat diseases of aging, offering the ability for people to live longer, healthier lives. Sirtris has focused on developing many novel small molecule activators of SIRT1, the most studied member of the sirtuin family. These new chemical entities or NCEs are novel compounds that are chemically unrelated to resveratrol, a naturally occurring compound that was used as an early proof-of-concept for SIRT1 activation. Besides being structurally differentiated from resveratrol, the NCEs are more specific for the target SIRT1 and have improved drug-like properties. The company has completed several early stage translational clinical studies with the first generation NCEs and has several active clinical trials under way. Sirtris operates as an independent Discovery Performance Unit (DPU) within GSK and is located in Technology Square, Cambridge, Mass. Sirtris' culture mixes scientific curiosity with a dynamic, fast-paced environment, resembling its biotech roots while harnessing all of GSK's broad discovery, development, and commercialization capabilities. The company was founded in 2004 and is headquartered in Cambridge, MA. | 11 años |
Ivan Delevic | M | 59 |
MAKO Surgical Corp.
MAKO Surgical Corp. Medical SpecialtiesHealth Technology MAKO Surgical Corp. is a medical device company, which develops and markets advanced robotic arm solution, joint specific applications for the knee, hip and orthopedic implants for orthopedic procedures. It also provides RIO robotic arm interactive orthopedic system, including a tactile robotic arm utilizing an integrated bone cutting instrument and a patient specific visualization component. The company was founded by Maurice R. Ferre and Rony A. Abovitz in November 2004 and is headquartered in Fort Lauderdale, FL. | 4 años |
Guy MacDonald | M | 65 | 11 años | |
Mark A. Reiley | M | 74 | 11 años | |
Gianna M. Bosko | F | 54 | 10 años | |
Scott W. Borland | M | 53 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | - |
David M. Shaw | M | 57 | 6 años | |
Russell C. Hirsch | M | 62 | 10 años | |
Timothy Nelson | M | 60 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | 8 años |
Steven van Dick | M | 69 | 5 años | |
David Savello | M | 78 | - | |
Dan Bradford | M | - | - | |
Joseph Mandato | M | 80 | 6 años | |
Henry Ward Wolff | M | 75 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | 5 años |
Peter Osborne | M | 67 | 1 años | |
Karl D. Handelsman | M | 63 | 7 años | |
Matt McPherron | M | 59 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | 7 años |
William J. Dower | M | - | - | |
Patrick Heron | M | 53 | 8 años | |
Robert Mark Weisskoff | M | 61 | 6 años | |
Jim M. Shapiro | M | 65 | 8 años | |
Robert W. Overell | M | 69 | 6 años | |
Raimonds Dzelme | M | - | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 100 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- John Freund
- Red Personal